Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted pregnant women; however, it yielded no improvements in diabetes symptoms. While metformin reduced maternal weight gain, its effects on primary diabetes symptoms and other secondary outcomes like infant weight gain were mixed, indicating a need for further focused research to unravel these associations.

Related Keywords

Ireland ,Irish ,Arturs Budkevics ,Drug Administration ,Early Metformin ,Image Credit ,Diabetes Treatment Satisfaction Questionnaire ,Diabetes ,Gestational Diabetes ,Metformin ,Flood ,Arbohydrate ,Clinical Trial ,Diabetes Mellitus ,Exercise ,Casting ,Global Health ,Glucose ,Hyperglycemia ,Hypoglycemia ,Insulin ,Intensive Care ,Jaundice ,Laboratory ,Neonatal Intensive Care ,Placebo ,Pregnancy ,Research ,Espiratory ,Type 2 Diabetes ,